ArticleMolecules (Basel, Switzerland)2020
Target-Guided Isolation of
Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed, 11 citations in OpenAlex.
- Identification of Steroidal Alkaloids with In Vitro Antiprotozoal Activity fromMolecules (Basel, Switzerland) · 2026Article
- Antiprotozoal Aminosteroid Alkaloids fromMolecules (Basel, Switzerland) · 2025Article
- Antiprotozoal Aminosteroids fromMolecules (Basel, Switzerland) · 2025Article
- Separation Methods of Phenolic Compounds from Plant Extract as Antioxidant Agents Candidate.Plants (Basel, Switzerland) · 2024Review
- Magnoflorine fromInternational journal of molecular sciences · 2023Article
- Investigation of the Variability of Alkaloids inMolecules (Basel, Switzerland) · 2021Article
- Identification of Antiprotozoal Compounds fromMolecules (Basel, Switzerland) · 2021Article
- AntiprotozoalAntibiotics (Basel, Switzerland) · 2021Article
- The Alkaloid-Enriched Fraction ofMolecules (Basel, Switzerland) · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
The increasing drug resistance of malaria parasites challenges the treatment of this life-threatening disease. Consequently, the development of innovative and effective antimalarial drugs is inevitable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.